Pfizer reported revenue below-the-expectations

By: Miguel A. Rodriguez

17:10, 27 October 2020

Pfizer reported mixed quarterly figures. The company’s waiting for the independent monitor to approve its potential COVID-19 vaccine

After it announced the lengths that will go to in order to have the proper conditions to distribute its potential COVID-19 vaccine, Pfizer made public its Q3 earnings.

The New York-based company reported earnings per share of 0.72 cents on revenue of $12.13 billion. While the EPS came higher than the 0.69 cents expected, the revenue fell short of the $12.31 billion mark.

Along with the Q3 figures came other news. According to Pfizer’s statement, the company’s not ready to go public with the data it collected during the late-stage trials of its potential COVID-19 vaccine that it’s developing alongside Germany’s BioNTech. Pfizer said that the independent monitor hadn’t conducted an in-depth analysis to show whether the drug was efficient.

Since the beginning of the year, the company’s stock price fell 3%, while USA500 gained 4.45%.

Read here more about Pfizer!


Share this article

This information/research prepared by Miguel A. Rodriguez does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. The research analyst primarily responsible for the content of this research report, in part or in whole, certifies that the views about the companies and their securities expressed in this report accurately reflect his/her personal views and consequently any person acting on it does so entirely at their own risk.The research provided does not constitute the views of KW Investments Ltd nor is it an invitation to invest with KW Investments Ltd. The research analyst also certifies that no part of his/her compensation was, is, or will be, directly, or indirectly, related to specific recommendations or views expressed in this report.The research analyst in not employed by KW Investments Ltd. You are encouraged to seek advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit that conforms to your specific investment objectives, financial situation, or particular financial needs before making a commitment to invest. The laws of the Republic of Seychelles shall govern any claim relating to or arising from the contents of the information/ research provided.